AUBURN, NEW HAMPSHIRE
-- January 31st, 2017
-- Sunrise Labs Inc., an ISO-13485 certified product development firm, partnered with H&T Presspart, a manufacturer for the drug delivery industry, to develop an electronic metered dose inhaler to improve adherence and enhance monitoring of patients with asthma and COPD.
Sunrise worked closely with H&T Presspart to create a design to meet their need for a miniaturized PCB, with very low power consumption, a robust integrated enclosure design, and connectivity to a smartphone. The new product is marketed under the brand name eMDI™. Its design features an FDA approved mechanical dose counter, with added electronics and bluetooth radios that communicate the device’s data to an app, “BreatheSmart,” developed by Cohero Health.
Sunrise was selected for this project based on its extensive knowledge of cybersecurity protocols, bluetooth /wireless technology, battery and power management, and sensor integration, along with deep experience developing FDA regulated medical devices and consumables.
“Improving the standard of care and patient outcomes is what we define as success,” said Eric Soederberg, President of Sunrise Labs, Inc. “We’re proud to have supported H&T Presspart and Cohero Health to develop the next generation of MDI devices using bluetooth technology for enhanced dosage monitoring, while leveraging an existing, compact design.”
About H&T Presspart
offers pharmaceutical customers high-precision injection moulded plastic components and deep drawn metal cans for respiratory drug delivery systems, with more than 40 years’ experience and a worldwide reputation for competence, quality, and innovation in pharmaceutical and industrial sectors. H&T Presspart Inhalation Product Technology Centre (IPTC) supports new product developments and strategic initiatives with its customers. Founded in 1970 and acquired by the Heitkamp and Thumann group in 2002, H&T Presspart has 3 European manufacturing sites in Germany, Spain and the UK, with Sales offices in China, India, South America and the USA.
For media and journalist inquiries, please contact:
+1 (919) 345-6240